Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMUNOTECH-B

3.160
-0.030-0.94%
Volume:176.00K
Turnover:555.28K
Market Cap:1.63B
PE:-7.97
High:3.350
Open:3.350
Low:3.040
Close:3.190
Loading ...

Company Profile

Company Name:
IMMUNOTECH-B
Exchange:
SEHK
Establishment Date:
2006
Employees:
154
Office Location:
Guosheng Technology Park,8th Floor, Block 1,No.1 Kangding Street,Beijing Eco-Tech Dev Area,Beijing,China
Zip Code:
- -
Phone:
- -
Fax:
86 10 8840 0152
Introduction:
Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.

Directors

Name
Position
TAN Zheng
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
WANG
Executive Director
WANG Ying Dian
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
CHI KIT NG
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
PENG Su Jiu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
WANG Rui Hua
Director
YANG Fan
Director
WANG Dong Hu
Director
YU Xiao Hui
Director,Audit Committee Member

Shareholders

Name
Position
ZHANG Jian
Acting CEO,Vice General Manager
WANG
CEO,Other Senior Executives
LIANG Rui Bing
Corporate Secretary
ZHENG Xuan Zhe
Other Senior Executives